Patients with relapsed/refractory (R/R) multiple myeloma and lower socioeconomic status reported significantly worse quality of life and a higher burden of symptoms, according to Francesco Sparano, ...

Seoul St. Mary's Hospital, which established the first blood hospital in Korea, revealed the results of the treatment of ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...

leading to the overproduction of abnormal proteins that can cause damage to bones, kidneys, and the immune system. 2 Today, treatment for multiple myeloma often involves an intensive combination ...

Multiple myeloma is a kind of blood cancer that starts ... Without treatment, these cells continue to grow and can cause serious complications in many parts of your body. With fewer healthy ...

Wyost and Jubbonti are interchangeable with Xgeva/Prolia and are approved for all of the same indications in bone cancer and osteoporosis.

A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Skepticism still persists around the use of measurable residual disease (MRD) for clinical and regulatory decision-making in ...

About a month ago, I woke up without hearing in my left ear. I initially suspected a wax blockage or a blocked eustachian ...

While older millennials currently have the the highest rates, researchers believe cases may continue to rise among younger generations.